Rheumatoid Arthritis, DMARD-naive and Early Disease Patients
1 clinical trials · Condition
◉ Watch Rheumatoid Arthritis, DMARD-naive and Early Disease Patients
| Record | Firm | Date |
|---|---|---|
| A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in DMARD-naïve Patients With Early Rheumatoid Arthritis (NCT03163966) | Rottapharm Biotech | 2017-10-05 |
Track Rheumatoid Arthritis, DMARD-naive and Early Disease Patients automatically
Every clearance here is in the API, with alerts when new ones post.